Physician profile
Jay Randall Erickson
NPI 1558363077
$1,822.06
in general payments reported to CMS, 2019-2025
33 companies · $374 in 2025
The $374 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $379 · 2020: $172 · 2021: $325 · 2022: $205 · 2023: $80.38 · 2024: $286 · 2025: $374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $740.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $420.30 | 2019-2025 | |
| Astellas Pharma US INC | $288.92 | 2019-2025 | Veozah, Myrbetriq |
| Optumhealth Care Solutions, LLC | $117.34 | 2024-2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Lilly USA, LLC | $106.11 | 2020-2024 | Zepbound |
| Therapeuticsmd, INC. | $94.59 | 2019-2022 | |
| Sage Therapeutics, LLC | $89.38 | 2021-2025 | Zurzuvae |
| Aspira Women'S Health INC | $76.19 | 2021 | |
| Mayne Pharma Commercial LLC | $73.29 | 2024-2025 | |
| Coloplast Corp | $50.58 | 2019-2021 | |
| Exeltis, USA INC. | $44.60 | 2021-2025 | Slynd |
| Lupin INC. | $40.46 | 2019 | |
| Pfizer INC. | $34.32 | 2020-2024 | |
| Intuitive Surgical, INC. | $32.29 | 2020 | |
| Daiichi Sankyo INC. | $31.63 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.15 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kedrion Biopharma, INC. | $24.76 | 2025 | Koate, Albuked, Kedrab |
| Myovant Sciences INC. | $24.61 | 2021 | |
| Hydrofera LLC | $21.46 | 2025 | Cutimed Sorbact |
| Exact Sciences Corporation | $20.28 | 2023 | Cologuard Collection Kit |
| Seqirus USA INC | $18.76 | 2025 | Flucelvax |
| Smith+Nephew, INC. | $16.74 | 2025 | Pico |
| Mylan Pharmaceuticals INC. | $15.71 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $15.50 | 2025 | Exparel |
| Merck Sharp & Dohme LLC | $15.30 | 2021 | |
| Amag Pharmaceuticals, INC. | $14.60 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $14.28 | 2023 | Ajovy |
| Supernus Pharmaceuticals, INC. | $14.17 | 2025 | Qelbree |
| Bayer Healthcare Pharmaceuticals INC. | $14.08 | 2025 | |
| Organon LLC | $12.76 | 2025 | Nexplanon |
| Evofem Biosciences, INC. | $12.65 | 2021 | |
| Duchesnay USA Incorporated | $12.39 | 2019 | |
| Agile Therapeutics, INC. | $12.11 | 2021 | |
| Amgen INC. | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Erickson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.